<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00854217</url>
  </required_header>
  <id_info>
    <org_study_id>2009/03FEV/047</org_study_id>
    <nct_id>NCT00854217</nct_id>
  </id_info>
  <brief_title>Cardioprotective Effects of Endogenous Erythropoietin in Patients Undergoing Coronary Artery Bypass Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <brief_summary>
    <textblock>
      Several studies have highlighted the cardioprotective effects of acute normovolemic
      hemodilution during cardiac surgery. The aim of our study is to show that an increase in
      endogenous erythropoietin (EPO) might explain the cardioprotective effects of acute
      normovolemic hemodilution against ischemia-reperfusion phenomena.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The major physiologic function of EPO is thought to be the induction of erythropoiesis.
      However, a growing body of evidence indicates that EPO has tissue-protective effects and
      prevents tissue damage during ischemia. In an ex vivo proof-of-concept, protective effects of
      EPO have been shown in human myocardium.

      Several studies have demonstrated that acute normovolemic hemodilution before aortic cross
      clamping decreases perioperative myocardial damage. We hypothesized that the onset of acute
      anemia increases the endogenous EPO concentration, which explains the cardioprotective
      effects of acute normovolemic hemodilution.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in Troponin -I values</measure>
    <time_frame>4 h</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>placebo, hemodilution</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>acute normovolemic hemodilution</intervention_name>
    <arm_group_label>placebo, hemodilution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients between 18 and 80 years old undergoing CABG with or without cardiopulmonary
             bypass

        Exclusion Criteria:

          -  emergencies

          -  redo operations

          -  combined surgery

          -  men with Hb&lt; 120g/dL and women with Hb&lt; 110g/ dL

          -  patients with preoperative creatinine&gt; 2.2 mg/dL

          -  poor ventricular function (EF &lt; 50%)

          -  subjects with a pulmonary disease, hepatic disease

          -  subjects with carotid stenosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cliniques Universitaires saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Licker M, Sierra J, Kalangos A, Panos A, Diaper J, Ellenberger C. Cardioprotective effects of acute normovolemic hemodilution in patients with severe aortic stenosis undergoing valve replacement. Transfusion. 2007 Feb;47(2):341-50. Erratum in: Transfusion. 2014 Nov;54(11):3019-20.</citation>
    <PMID>17302782</PMID>
  </reference>
  <reference>
    <citation>Licker M, Ellenberger C, Sierra J, Kalangos A, Diaper J, Morel D. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest. 2005 Aug;128(2):838-47.</citation>
    <PMID>16100176</PMID>
  </reference>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2009</study_first_submitted>
  <study_first_submitted_qc>March 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2009</study_first_posted>
  <last_update_submitted>March 2, 2011</last_update_submitted>
  <last_update_submitted_qc>March 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>Mona Momeni, MD</name_title>
    <organization>Cliniques Universitaires saint Luc</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

